Abstract:Background Biliary atresia (BA) is a childhood liver disease characterized by fibrous obstruction and obstruction of the extrahepatic biliary system and is one of the most common and serious biliary disorders in infants. Significant inflammation and fibrosis of the liver and biliary tract are the most prominent features, regardless of the initial damage to the BA. Abnormalities in innate or adaptive immunity have been found in human patients and mouse models of BA. We previously reported that children with BA had abnormal lipid metabolism, including free serum carnitine. Objective To study gene and protein expression levels of the hepatic peroxisome proliferator-activated receptor-α (PPARα) signaling pathway and farnesoid X receptor (FXR) in BA and BA fibrosis, and assess their clinical values. Methods Low expression of PPARα and NR1H4 (FXR) in BA were validated in the Gene Expression Omnibus database. Functional differences were determined by gene set enrichment analysis based on of PPARα and NR1H4 expression. BA patients from GSE46960 were divided into two clusters by using consensus clustering according to PPARα, NR1H4, and SMAD3 expression levels, and immunoinfiltration analysis was performed. Finally, 58 cases treated in our hospital were used for experimental verification. (IHC: 10 Biliary atresia, 10 choledochal cysts; PCR: 10 Biliary atresia, 14 choledochal cysts; WB: 10 Biliary atresia, 4 choledochal cysts). Results Bioinformatics analysis showed that the expression of PPARα, CYP7A1 and NR1H4 (FXR) in the biliary atresia group was significantly lower than in the control group. More BA-specific pathways, including TGFβ signaling pathway, P53 signaling pathway, PI3K-AKT-mTOR signaling pathway, etc., are enriched in BA patients with low PPARα and NR1H4 expression. In addition, low NR1H4 expression is abundant in inflammatory responses, IL6/STAT3 signaling pathways, early estrogen responses, IL2 STAT5 signaling pathways, and TGFβ signaling pathways. The TGFβ signaling pathway was significant in both groups. According to the expression of PPARα, NR1H4 and SMAD3, a key node in TGFβ pathway, BA patients were divided into two clusters using consensus clustering. In cluster 2, SMAD3 expression was high, and PPARα and NR1H4 expression were low. In contrast to cluster 1, immune cell infiltration was higher in cluster 2, which was confirmed by immunohistochemistry. The mRNA and protein levels of PPARα and NR1H4 in BA patients were lower than in the control group by immunohistochemistry, Western blot analysis and real-time PCR. Conclusions The downregulation of PPARα and NR1H4 (FXR) signaling pathway may be closely related to biliary atresia.

MicroRNA-19b Expression in Human Biliary Atresia Specimens and Its Role in BA-Related Fibrosis

MicroRNA-21/PTEN/Akt Axis in the Fibrogenesis of Biliary Atresia

Mir-222 Overexpression May Contribute to Liver Fibrosis in Biliary Atresia by Targeting Ppp2r2a

The Aberrant Expression of HLA-DR in Intrahepatic Bile Ducts in Patients with Biliary Atresia: an Immunohistochemistry and Immune Electron Microscopy Study.

Long non-coding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia.

MicroRNA-29b/142-5p Contribute to the Pathogenesis of Biliary Atresia by Regulating the IFN-γ Gene

Effect of Microrna-155 on the Interferon-Gamma Signaling Pathway in Biliary Atresia

Serum Microrna Microarray Analysis Identifies Mir-4429 and Mir-4689 Are Potential Diagnostic Biomarkers for Biliary Atresia

microRNA-222 modulates liver fibrosis in a murine model of biliary atresia.

Identification of Liver Immune Microenvironment-Related Hub Genes in Liver of Biliary Atresia

MicroRNA-499 Rs3746444 Polymorphism and Biliary Atresia.

CircUTRN24/miR-483-3p/IGF-1 Regulates Autophagy Mediated Liver Fibrosis in Biliary Atresia

Expression of miRNA-19b in Hepatic Fibrosis Rats

Single‐cell and spatial transcriptomics reveal the fibrosis‐related immune landscape of biliary atresia

LncRNA MEG9 Promotes Inflammation and Liver Fibrosis Through S100A9 in Biliary Atresia

Preliminary Exploration on Silencing of Microrna-222 for Improving Liver Fibrosis in a Murine Model of Biliary Atresia

Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling

Reduced peroxisome proliferator-activated receptor-α and bile acid nuclear receptor NR1H4/FXR may affect the hepatic immune microenvironment of biliary atresia

The Expression of Epithelial–mesenchymal Transition–related Proteins in Biliary Epithelial Cells is Associated with Liver Fibrosis in Biliary Atresia

Hsa_circ_0009096/miR-370-3p modulates hepatic stellate cell proliferation and fibrosis during biliary atresia pathogenesis

The association of immune-related genes and the potential role of IL10 with biliary atresia